SCHEMBL29115503

SCHEMBL29115503

O=C(N[C@@H]1CCOC1)c1ccc(N2CCNCC2)c(Cl)c1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 6/20 0.46
MAPT P10636 3/20 0.45
ALDH1A1 P00352 2/20 0.45
DGAT2 Q96PD7 1/20 0.44
POLB P06746 4/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
USP30 Q70CQ3 1/20 0.42
LMNA P02545 1/20 0.42
MAPK1 P28482 1/20 0.42
HTT P42858 1/20 0.42
PARP1 P09874 2/20 0.42
UTS2R Q9UKP6 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29960542 1.00 NAMPT (0.46) NAMPTMAPTALDH1A1DGAT2POLB
SCHEMBL29115504 1.00 NAMPT (0.46) NAMPTMAPTALDH1A1DGAT2POLB
SCHEMBL29085200 0.88 USP30 (0.56) NAMPTMAPTALDH1A1POLBSMN1; SMN2
SCHEMBL29960478 0.88 USP30 (0.56) NAMPTMAPTALDH1A1POLBSMN1; SMN2
SCHEMBL29085175 0.88 USP30 (0.56) NAMPTMAPTALDH1A1POLBSMN1; SMN2
SCHEMBL29085179 0.88 USP30 (0.56) NAMPTMAPTALDH1A1POLBSMN1; SMN2
SCHEMBL531843 0.87 POLB (0.52) MAPTALDH1A1POLBMEN1KMT2A
SCHEMBL20339517 0.85 CNR2 (0.51) MAPTALDH1A1POLBMEN1KMT2A
SCHEMBL29115593 0.83 MAPT (0.50) MAPTALDH1A1POLBSMN1; SMN2MEN1
SCHEMBL30064567 0.82 USP30 (0.47) NAMPTMAPTALDH1A1USP30NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116710433-A Selective PARP1 inhibitor and application thereof 成都百裕制药股份有限公司 2023-09-05 CN disclosed
WO-2022222966-A1 SELECTIVE PARP1 INHIBITOR AND APPLICATION THEREOF 成都百裕制药股份有限公司 2022-10-27 WO disclosed